UnitedHealth Group Incorporated (NYSE:UNH) Stake Cut by Elite Wealth Management Inc.

Elite Wealth Management Inc. reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 28.5% in the 3rd quarter, Holdings Channel reports. The fund owned 1,752 shares of the healthcare conglomerate’s stock after selling 700 shares during the period. Elite Wealth Management Inc.’s holdings in UnitedHealth Group were worth $685,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in UNH. Amundi purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $680,292,000. Jennison Associates LLC increased its position in UnitedHealth Group by 205.8% in the 2nd quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock worth $779,944,000 after purchasing an additional 1,310,783 shares during the last quarter. Macquarie Group Ltd. increased its position in UnitedHealth Group by 311.9% in the 2nd quarter. Macquarie Group Ltd. now owns 1,622,199 shares of the healthcare conglomerate’s stock worth $649,595,000 after purchasing an additional 1,228,389 shares during the last quarter. State Street Corp increased its position in UnitedHealth Group by 1.9% in the 2nd quarter. State Street Corp now owns 44,530,535 shares of the healthcare conglomerate’s stock worth $17,831,807,000 after purchasing an additional 838,941 shares during the last quarter. Finally, Morgan Stanley increased its position in UnitedHealth Group by 9.7% in the 2nd quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock worth $3,481,120,000 after purchasing an additional 768,188 shares during the last quarter. 86.20% of the stock is owned by hedge funds and other institutional investors.

UNH has been the topic of several research reports. Credit Suisse Group upped their target price on UnitedHealth Group from $462.00 to $495.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $421.00 to $477.00 and gave the company a “buy” rating in a report on Tuesday, November 16th. SVB Leerink started coverage on UnitedHealth Group in a report on Monday, September 27th. They set an “outperform” rating and a $480.00 price objective on the stock. Mizuho increased their price objective on UnitedHealth Group from $455.00 to $500.00 and gave the company a “buy” rating in a report on Wednesday, November 10th. Finally, BMO Capital Markets increased their price objective on UnitedHealth Group from $435.00 to $475.00 and gave the company a “market perform” rating in a report on Monday, October 18th. One equities research analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $477.35.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total value of $1,041,875.00. Following the completion of the transaction, the director now owns 154,403 shares in the company, valued at approximately $64,347,450.25. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stephen J. Hemsley sold 75,000 shares of UnitedHealth Group stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 82,500 shares of company stock valued at $36,855,125 in the last 90 days. 0.55% of the stock is owned by corporate insiders.

Shares of UNH stock opened at $439.91 on Friday. The stock has a 50 day moving average of $431.53 and a two-hundred day moving average of $418.41. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59. UnitedHealth Group Incorporated has a 12 month low of $320.35 and a 12 month high of $466.00. The company has a market capitalization of $414.33 billion, a P/E ratio of 27.29, a P/E/G ratio of 1.75 and a beta of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to the consensus estimate of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. UnitedHealth Group’s revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the company earned $3.51 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be given a dividend of $1.45 per share. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a dividend yield of 1.32%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.98%.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: Trading Ex-Dividend Strategy

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.